在选择的神经疾病中使用基于大麻的药物
Natalia Szejko1, Kamila Saramak2, Kirsten R Müller-Vahl3
1Clinic of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
Current topics in behavioral neurosciences
|December 31, 2024
概括
基于大麻的药物对神经系统疾病,特别是图雷特综合征有很大的前景,改善了. 有限的证据表明,对帕金森病和亨廷顿病的症状有好处.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于大麻的药物 (CBM) 已建立用于治疗疼痛,食欲丧失和性.
- 它在运动和神经退行性疾病中的应用是一个新兴的研究领域.
研究的目的:
- 审查关于CBM在神经疾病中的使用现有证据,重点关注运动和神经退行性疾病.
主要方法:
- 对CBM在神经疾病中的疗效现有研究的文献综述.
主要成果:
- 最强有力的证据支持CBM治疗图雷特综合征,改善滴答和精神问题,建议使用含有delta-9-tetrahydrocannabinol (THC) 的CBM.
- 有限的证据表明CBM可能有助于帕金森病的症状 (发,非运动症状) 和亨廷顿病的行为症状.
- 对CBM的潜在神经保护作用是推测性的,在临床上没有得到证实.
结论:
- 在某些神经疾病中,CBM显示已确立的有效性,而在其他疾病中则显示出新兴的潜力.
- 需要进一步的临床研究来证实神经保护作用,并扩大CBM在神经退行性疾病中的应用.
更多相关视频
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
126
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
126
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
184
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
184
Brain Imaging
193
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
193
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
84
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
84
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303
Disorders of the Nervous Tissue
926
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
926


